Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 10/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 7/20 | 0.53 |
| ▸ | ACE | P12821 | 7/20 | 0.53 |
| ▸ | CPA1 | P15085 | 6/20 | 0.53 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | MMP7 | P09237 | 1/20 | 0.49 |
| ▸ | MMP9 | P14780 | 1/20 | 0.49 |
| ▸ | MMP12 | P39900 | 1/20 | 0.49 |
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29670408 | 0.99 | MME (0.52) | MMEACE2ACECPA1MMP2 | |
| SCHEMBL22457541 | 0.94 | MME (0.56) | MMEACE2ACECPA1 | |
| SCHEMBL13744198 | 0.86 | HDAC3 (0.48) | MMEACE2ACECPA1MMP2 | |
| SCHEMBL30534368 | 0.83 | MME (0.48) | MMEACE2ACECPA1MMP2 | |
| SCHEMBL29670351 | 0.82 | ABCB1 (0.52) | MMEACE2ACECPA1 | |
| SCHEMBL22457647 | 0.82 | MME (0.67) | MMEACE2ACECPA1 | |
| Hydrochloric Acid SCHEMBL29670155 | 0.81 | MME (0.65) | MMEACE2ACECPA1 | |
| SCHEMBL13743922 | 0.80 | ACE (0.49) | MMEACE2ACECPA1MMP2 | |
| SCHEMBL30522102 | 0.80 | MMP9 (0.46) | MMEACE2ACECPA1MMP2 | |
| SCHEMBL29540417 | 0.80 | LTA4H (0.51) | MMEACELTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153777-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | NISSAN CHEMICAL CORPORATION (JP) | 2022-05-19 | — | — | US | disclosed |
| WO-2020189621-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | 日産化学株式会社 | 2020-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153777-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | NGLY1, NPPA, NPEPPS | MME 67/4885ACE2 1436/4885ACE 982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.